TNFSF13B and Miyoshi myopathy: BCMA (CD269), the major target for BsAb in MM, is a member of the tumor necrosis factor receptor (TNFR) family which promotes cell proliferation and survival after binding its ligands APRIL (A Proliferation Inducing Ligand) and BAFF (B cell Activating Factor).